evaluated an immunohistochemical assay targeting the AFF2 C-terminus, demonstrating 100% sensitivity and specificity for DEK::AFF2 sinonasal carcinomas. This evidence concerns the gene AFF2 and nasal cavity and paranasal sinus carcinoma.